GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Pharmaceutical ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...
Takeda has announced a global collaboration and licence agreement with Halozyme to continue advancing vedolizumab with the ...
Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions ...
Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA / ACCESS Newswire / January 12, 2026 / Amphastar Pharmaceuticals, ...
The Chosun Ilbo on MSN
Global and Korean Pharma Race Alzheimer's Drug Development
U.S. pharmaceutical company Eli Lilly plans to disclose the top-line results of its phase 3 clinical trial for ‘remternutux,’ a new drug candidate being developed as a successor to its Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback